Vivani Medical Inc Quick Ratio (VANI) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Vivani Medical Inc   (NASDAQ: VANI)

Vivani Medical Inc 's Quick Ratio

VANI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Vivani Medical Inc 's Cash & cash equivalent grew by 0.73 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Vivani Medical Inc 's Quick Ratio to 2.99, Quick Ratio remained below Vivani Medical Inc average.

Within Medical Equipment & Supplies industry 59 other companies have achieved higher Quick Ratio than Vivani Medical Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 864 to 1002.

Explain Quick Ratio?
How much Cash & cash equivalents VANI´s has?
What are VANI´s Current Liabilities?




VANI Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -0.85 % 9.29 % 10.29 % 8.93 % 16.11 %
Y / Y Cash & cash equivalent Change 192.82 % 51.82 % -11.55 % -86.62 % -72.74 %
Quick Ratio MRQ 2.99 2.91 2.46 0.38 1.01
VANI's Total Ranking # 1002 # 864 # 0 # 2230 # 1381
Seq. Current Liabilities Change -1.71 % 2.62 % -3.34 % 1.7 % 8.34 %
Seq. Cash & cash equivalent Change 0.73 % 21.67 % 517.66 % -61.32 % -47.77 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 404
Overall Market # 1002


Quick Ratio Statistics
High Average Low
28.27 5.22 0.38
(Dec 31 2021)   (Sep 30 2025)




Financial Statements
Vivani Medical Inc 's Current Liabilities $ 7 Millions Visit VANI's Balance sheet
Vivani Medical Inc 's Cash & cash equivalent $ 20 Millions Visit VANI's Balance sheet
Source of VANI's Sales Visit VANI's Sales by Geography


Cumulative Vivani Medical Inc 's Quick Ratio

VANI's Quick Ratio for the trailling 12 Months

VANI Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 6.73 % 11.07 % 8.97 % 0.48 % -5.97 %
Y / Y Cash & cash equivalent TTM Growth 1.22 % -40.2 % -58.23 % -57.01 % -42.22 %
Quick Ratio TTM 2.18 1.69 1.47 1.58 2.3
Total Ranking TTM # 3911 # 2837 # 0 # 2953 # 2748
Seq. Current Liabilities TTM Growth -0.21 % 2.19 % 2.39 % 2.22 % 3.85 %
Seq. Cash & cash equivalent TTM Growth 28.85 % 17.44 % -5.2 % -29.44 % -23.87 %


On the trailing twelve months basis VANI Cash & cash equivalent more than doubled by 192.82 % in Q2 2026 year on year, while Current Liabilities decreased to $7 millions, this led to increase in in Vivani Medical Inc 's Quick Ratio to 2.18, Quick Ratio remained below VANI average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 198 other companies have achieved higher Quick Ratio than Vivani Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2837 to 3911.

Explain Quick Ratio?
How much Cash & cash equivalents VANI´s has?
What are VANI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 199
Healthcare Sector # 886
Within the Market # 3911


trailing twelve months Quick Ratio Statistics
High Average Low
22.68 4.77 0.71
(Jun 30 2022)   (Dec 31 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions

Date modified: 2026-09-02T21:02:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.